Hester Biosciences Limited - Asset Resilience Ratio

Latest as of September 2025: 4.41%

Hester Biosciences Limited (HESTERBIO) has an Asset Resilience Ratio of 4.41% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Hester Biosciences Limited's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs298.06 Million
≈ $3.22 Million USD Cash + Short-term Investments

Total Assets

Rs6.75 Billion
≈ $73.02 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Hester Biosciences Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Hester Biosciences Limited.

Liquid Assets Composition Over Time

This chart breaks down Hester Biosciences Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Hester Biosciences Limited to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs79.38 Million 1.18%
Short-term Investments Rs218.68 Million 3.24%
Total Liquid Assets Rs298.06 Million 4.41%

Asset Resilience Insights

  • Limited Liquidity: Hester Biosciences Limited maintains only 4.41% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hester Biosciences Limited Industry Peers by Asset Resilience Ratio

Compare Hester Biosciences Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Yunnan Baiyao Group Co Ltd
SHE:000538
Drug Manufacturers - Specialty & Generic 8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Jiuzhitang Co Ltd
SHE:000989
Drug Manufacturers - Specialty & Generic 7.86%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for Hester Biosciences Limited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Hester Biosciences Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.19% Rs12.54 Million
≈ $135.62K
Rs6.53 Billion
≈ $70.66 Million
-0.19pp
2024-03-31 0.39% Rs25.56 Million
≈ $276.42K
Rs6.62 Billion
≈ $71.63 Million
-2.97pp
2023-03-31 3.35% Rs183.07 Million
≈ $1.98 Million
Rs5.46 Billion
≈ $59.03 Million
+3.27pp
2022-03-31 0.08% Rs4.53 Million
≈ $48.99K
Rs5.62 Billion
≈ $60.80 Million
+0.01pp
2021-03-31 0.07% Rs2.93 Million
≈ $31.69K
Rs4.11 Billion
≈ $44.45 Million
-6.05pp
2020-03-31 6.12% Rs235.31 Million
≈ $2.54 Million
Rs3.84 Billion
≈ $41.58 Million
-7.11pp
2019-03-31 13.23% Rs396.25 Million
≈ $4.29 Million
Rs2.99 Billion
≈ $32.38 Million
+11.70pp
2018-03-31 1.54% Rs37.51 Million
≈ $405.61K
Rs2.44 Billion
≈ $26.39 Million
+1.51pp
2017-03-31 0.02% Rs478.82K
≈ $5.18K
Rs2.18 Billion
≈ $23.59 Million
+0.31pp
2016-03-31 -0.29% Rs-5.26 Million
≈ $-56.89K
Rs1.84 Billion
≈ $19.93 Million
--
pp = percentage points

About Hester Biosciences Limited

NSE:HESTERBIO India Drug Manufacturers - Specialty & Generic
Market Cap
$201.99 Million
Rs18.68 Billion INR
Market Cap Rank
#16602 Global
#856 in India
Share Price
Rs2195.60
Change (1 day)
-2.24%
52-Week Range
Rs1259.10 - Rs2545.00
All Time High
Rs3204.96
About

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl… Read more